SORT1 and schwannoma: The group demonstrated that a synthesized peptide containing the proneurotrophin-binding sequence in sortilin effectively blocked proneurotrophin binding and inhibited pro-NGF-induced cell death in the schwannoma cell line RN22, presumably by binding to and blocking the site on the proneurotrophin that would normally bind full-length sortilin.